公司资料
uniQure N.V. 股价、新闻与催化剂
- 股票代码:
- QURE
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Netherlands
股票表现
44.31 USD (+0.70%)
收盘价
最后更新: 2026年9月21日
1.69B USD
市值
股价为何变动
截至 2026年9月21日，QURE 上涨 0.70%，收于 $44.31。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
uniQure is a gene-therapy company focused on rare diseases and neurological disorders. Its platform and clinical programs make it one of the better-known names in viral-vector gene therapy.
所在地与行业分类
Headquartered in the Netherlands and listed on NASDAQ as an ADR, uniQure has a global gene-therapy footprint.
商业模式特征
The business is driven by clinical data, manufacturing capability, and the challenge of turning gene therapy into durable value.
生物医药行业定位
uniQure is a classic gene-therapy catalyst name whose valuation is highly sensitive to program and safety outcomes.
未来催化剂
- uniQure's catalysts are AMT-130 in Huntington's disease and the rest of its gene-therapy pipeline, where any clean clinical or regulatory step can matter a lot. The company still needs the next update to show the gene-therapy platform can keep building beyond a single program.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。